Literature DB >> 4351181

A tumor antigen in tissue cultures derived from patients with Hodgkin's disease.

J C Long, A C Aisenberg, M V Zamecnik, P C Zamecnik.   

Abstract

Pellets obtained from supernatant fluids of monolayer cultures of cells from patients with Hodgkin's disease were fractionated by isopycnic density sedimentation. Material in a peak of specific gravity 1.15-1.21 g/ml from two Hodgkin's disease cultures was used to immunize rabbits, and the antisera obtained in this manner were reacted by agar-gel diffusion and immunoelectrophoresis with antigens from the purified peaks and the unfractionated pellets of centrifuged culture medium from all the cultures. The antisera reacted with material from 9 of 10 lines derived from spleens of patients with Hodgkin's disease, 2 of 8 cell lines from histologically negative spleens from patients with Hodgkin's disease and with 3 of 6 lymphoma cell lines not diagnosed as Hodgkin's disease. The antisera did not react with 12 cell cultures prepared from normal adult and fetal spleen and thymus. The antigen from cultures from patients with Hodgkin's disease was not found in material sedimenting at lower specific gravities; it resisted Tweenether solubilization, and migrated as a single band by immunoelectrophoresis. The antigen was not found in disrupted, noncultured tumor cells from patients with Hodgkin's disease, and an antiserum against noncultured, minced tumor tissue did not react with the Hodgkin's disease tissue-culture material. No immunological relationship was found between the tissue culture antigen and Epstein-Barr, RD-114, or Rauscher murine leukemia viruses. The Hodgkin's disease antigen may be a tumorrelated antigen or a component of an oncogenic virus.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4351181      PMCID: PMC433538          DOI: 10.1073/pnas.70.5.1540

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Virus-like agents from patients with Hodgkin's disease.

Authors:  M Eisinger; S M Fox; E De Harven; J L Biedler; F K Sanders
Journal:  Nature       Date:  1971-09-10       Impact factor: 49.962

2.  Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease.

Authors:  B Johansson; G Klein; W Henle; G Henle
Journal:  Int J Cancer       Date:  1970-11-15       Impact factor: 7.396

3.  Production of immunoglobulins and their subunits by human tissue culture cell lines.

Authors:  J D Wakefield; G J Thorbecke; L J Old; E A Boyse
Journal:  J Immunol       Date:  1967-08       Impact factor: 5.422

4.  Biologically active water-insoluble protein polymers. I. Their use for isolation of antigens and antibodies.

Authors:  S Avrameas; T Ternynck
Journal:  J Biol Chem       Date:  1967-04-10       Impact factor: 5.157

5.  A difference in the architecture of the surface membrane of normal and virally transformed cells.

Authors:  M M Burger
Journal:  Proc Natl Acad Sci U S A       Date:  1969-03       Impact factor: 11.205

6.  Isolation of noninfectious particles containing Rous sarcoma virus RNA from the medium of Rous sarcoma virus-transformed nonproducer cells.

Authors:  H L Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1967-06       Impact factor: 11.205

7.  HL-A antigens from a continuous lymphoid cell line derived from a normal donor. I. Solubilization and serologic characterization.

Authors:  R A Reisfeld; M Pellegrino; B W Papermaster; B D Kahan
Journal:  J Immunol       Date:  1970-03       Impact factor: 5.422

8.  Viruses in human tumors. I. Hodgkin's disease.

Authors:  S E Stewart; E Z Mitchell; J J Whang; W R Dunlop; T Ben; S Nomura
Journal:  J Natl Cancer Inst       Date:  1969-07       Impact factor: 13.506

9.  Proteins of the murine C-type RNA tumour viruses: isolation of a group-specific antigen by isoelectric focusing.

Authors:  S Oroszlan; C L Fisher; T B Stanley; R V Gilden
Journal:  J Gen Virol       Date:  1970-07       Impact factor: 3.891

10.  Viruses in cell culture derived from human tumour patients.

Authors:  G J Todaro; V Zeve; S A Aaronson
Journal:  Nature       Date:  1970-06-13       Impact factor: 49.962

View more
  7 in total

1.  Sensitisation to Hodgkin's disease spleen tissue in patients with malignant lymphoma: follow-up study.

Authors:  B W Hancock; L Bruce; J Richmond
Journal:  Br Med J       Date:  1976-08-07

2.  Abnormalities of in vitro immunoglobulin synthesis by peripheral blood lymphocytes from untreated patients with Hodgkin's disease.

Authors:  S Romagnani; G F Del Prete; E Maggi; G Bellesi; G Biti; P L Rossi Ferrini; M Ricci
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

3.  Cellular immunity to Hodgkin's splenic tissue measured by leucocyte migration inhibition.

Authors:  B W Hancock; L Bruce; J Richmond
Journal:  Br Med J       Date:  1976-03-06

4.  [Carcinofetal antigens. III. Further carcinofetal antigens (author's transl)].

Authors:  R Lamerz; A Fateh-Moghadam
Journal:  Klin Wochenschr       Date:  1975-05-01

5.  Clinical significance of antibodies to ovarian antigens; association with cancer of the genito-urinary tract.

Authors:  A P Forbes; J R Lake; K J Bloch
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

6.  An antigen in Hodgkin's disease tissue cultures: radioiodine-labeled antibody studies.

Authors:  J C Long; A C Aisenberg; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1974-07       Impact factor: 11.205

7.  An antigen in Hodgkin's disease tissue cultures: fluorescent antibody studies.

Authors:  J C Long; A C Aisenberg; P C Zamecnik
Journal:  Proc Natl Acad Sci U S A       Date:  1974-06       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.